Troubleshooting problems with in vitro screening of drugs for QT interval prolongation using HERG K+ channels expressed in mammalian cell lines and Xenopus oocytes
Authors:
- Harry J. WitchelHWHarry J. Witchel
- James T. MilnesJMJames T. Milnes
- John S. MitchesonJMJohn S. Mitcheson
- Jules C. HancoxJHJules C. Hancox
- 1 September 2002
- journal article
- review article
- Published by Elsevier in Journal of Pharmacological and Toxicological Methods
- Vol. 48 (2) , 65-80
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- X-ray structure of a voltage-dependent K+ channelNature, 2003
- Disease‐associated mutations in KCNE potassium channel subunits (MiRPs) reveal promiscuous disruption of multiple currents and conservation of mechanismThe FASEB Journal, 2002
- Inhibition of the current of heterologously expressed HERG potassium channels by imipramine and amitriptylineBritish Journal of Pharmacology, 1999
- Modulation of HERG current andherg gene expression during retinoic acid treatment of human neuroblastoma cells: Potentiating effects of BDNFJournal of Neurobiology, 1999
- N‐linked glycosylation sites determine HERG channel surface membrane expressionThe Journal of Physiology, 1999
- Blockade of HERG channels by the class III antiarrhythmic azimilide: mode of actionBritish Journal of Pharmacology, 1998
- The Role of the Cap Structure in RNA Processing and Nuclear ExportEuropean Journal of Biochemistry, 1997
- KvLQT1 and IsK (minK) proteins associate to form the IKS cardiac potassium currentNature, 1996
- The inward rectification mechanism of the HERG cardiac potassium channelNature, 1996
- Functional characterization of a minimal potassium channel expressed from a synthetic geneBiochemistry, 1991